142 related articles for article (PubMed ID: 1255476)
1. Physiological disposition and biotransformation of [allyl-1', 3' - 14C naloxone in the rat and some comparative observations on nalorphine.
Misra AL; Pontani RB; Vadlamani NL; Mulé SJ
J Pharmacol Exp Ther; 1976 Feb; 196(2):257-68. PubMed ID: 1255476
[TBL] [Abstract][Full Text] [Related]
2. Physiological disposition and biotransformation of (3H) cocaine in acutely and chronically treated rats.
Nayak PK; Misra AL; Mulé SJ
J Pharmacol Exp Ther; 1976 Mar; 196(3):556-69. PubMed ID: 1263111
[TBL] [Abstract][Full Text] [Related]
3. Disposition of (15,16-3H)naltrexone in the central nervous system of the rat.
Misra AL; Bloch R; Vardy J; Mulé SJ; Verebely K
Drug Metab Dispos; 1976; 4(3):276-80. PubMed ID: 6233
[TBL] [Abstract][Full Text] [Related]
4. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H
Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
[TBL] [Abstract][Full Text] [Related]
5. Disposition and metabolism of [14C]-haloperidol in rats.
Miyazaki H; Matsunaga Y; Nambu K; Oh-e Y; Yoshida K; Hashimoto M
Arzneimittelforschung; 1986 Mar; 36(3):443-52. PubMed ID: 3707663
[TBL] [Abstract][Full Text] [Related]
6. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
[TBL] [Abstract][Full Text] [Related]
7. Disposition of naloxone: use of a new radioimmunoassay.
Berkowitz BA; Ngai SH; Hempstead J; Spector S
J Pharmacol Exp Ther; 1975 Dec; 195(3):499-504. PubMed ID: 1195133
[TBL] [Abstract][Full Text] [Related]
8. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 4th communication: absorption, metabolism, excretion and plasma protein binding in various animals and man.
Mizojiri K; Okabe H; Sugeno K; Misaki A; Ito M; Kominami G; Esumi Y; Takaichi M; Harada T; Seki H; Inaba A
Arzneimittelforschung; 1997 Mar; 47(3):259-69. PubMed ID: 9105544
[TBL] [Abstract][Full Text] [Related]
9. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
10. The seminal excretion, plasma elimination, tissue distribution and metabolism of naltrexone in the rabbit.
Taylor SM; Rodgers RM; Lynn RK; Gerber N
J Pharmacol Exp Ther; 1980 May; 213(2):289-99. PubMed ID: 7365688
[TBL] [Abstract][Full Text] [Related]
11. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
[TBL] [Abstract][Full Text] [Related]
12. Disposition and metabolism of [14C]-amezinium metilsulfate in rats.
Nambu K; Yoshida K; Kagemoto A; Matsumoto K; Miyazaki H; Hashimoto M; Esumi Y; Jin Y; Gunji S; Iwabuchi M
Arzneimittelforschung; 1988 Jul; 38(7):909-18. PubMed ID: 3207436
[TBL] [Abstract][Full Text] [Related]
13. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
14. The disposition and metabolism of a hypnotic benzodiazepine, quazepam, in the hamster and mouse.
Hilbert J; Pramanik B; Symchowicz S; Zampaglione N
Drug Metab Dispos; 1984; 12(4):452-9. PubMed ID: 6148212
[TBL] [Abstract][Full Text] [Related]
15. Levels of acetaminophen and its metabolites in mouse tissues after a toxic dose.
Fischer LJ; Green MD; Harman AW
J Pharmacol Exp Ther; 1981 Nov; 219(2):281-6. PubMed ID: 7288620
[TBL] [Abstract][Full Text] [Related]
16. Metabolism and excretion of a new antipsychotic drug, ziprasidone, in humans.
Prakash C; Kamel A; Gummerus J; Wilner K
Drug Metab Dispos; 1997 Jul; 25(7):863-72. PubMed ID: 9224781
[TBL] [Abstract][Full Text] [Related]
17. Metabolism and disposition of clarithromycin in man.
Ferrero JL; Bopp BA; Marsh KC; Quigley SC; Johnson MJ; Anderson DJ; Lamm JE; Tolman KG; Sanders SW; Cavanaugh JH
Drug Metab Dispos; 1990; 18(4):441-6. PubMed ID: 1976065
[TBL] [Abstract][Full Text] [Related]
18. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH
Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144
[TBL] [Abstract][Full Text] [Related]
19. The metabolic disposition of (S)-2-(3-tert-butylamino-2-hydroxypropoxy)-3-cyanopyridine in rats, dogs, and humans.
Vickers S; Duncan CA; Arison BH; Davies RO; Ferguson R; Zacchei AG
Drug Metab Dispos; 1980; 8(3):163-7. PubMed ID: 6104580
[TBL] [Abstract][Full Text] [Related]
20. Disposition of remoxipride in different species. Species differences in metabolism.
Widman M; Nilsson LB; Bryske B; Lundström J
Arzneimittelforschung; 1993 Mar; 43(3):287-97. PubMed ID: 8489555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]